Colgate-Palmolive (NYSE:CL) Shares Sold by Adirondack Trust Co.

Adirondack Trust Co. lessened its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,292 shares of the company’s stock after selling 207 shares during the period. Adirondack Trust Co.’s holdings in Colgate-Palmolive were worth $1,208,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive in the third quarter valued at about $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive in the 3rd quarter valued at about $53,000. Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive during the third quarter worth about $64,000. True Wealth Design LLC increased its stake in shares of Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after buying an additional 672 shares during the period. Finally, Continuum Advisory LLC raised its holdings in shares of Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after purchasing an additional 368 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CL. JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday, January 16th. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Barclays reduced their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Finally, UBS Group lowered their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $101.11.

Colgate-Palmolive Stock Down 0.8 %

Shares of NYSE:CL opened at $87.53 on Thursday. Colgate-Palmolive has a 12-month low of $80.03 and a 12-month high of $109.30. The stock’s 50-day moving average price is $92.00 and its two-hundred day moving average price is $97.58. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The firm has a market cap of $71.51 billion, a price-to-earnings ratio of 25.08, a PEG ratio of 3.62 and a beta of 0.44.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.28%. Colgate-Palmolive’s payout ratio is 57.31%.

Insider Buying and Selling

In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.